About

About SCIENCE BIOTECH It is a drug development company, holding an exclusive pipeline of innovative drugs. About Science Biotech It is a drug development company, holding an exclusive pipeline of innovative drugs. Science Biotech is a drug/devices developing company, focused in selling license agreements and/or patent rights. Science Biotech has sold last year a 1.5M USD patent rights for a Brazilian Pharmaceutical Company, and a license agreement of almost 20M USD in royalties, for the next 20 years. Right now, there are 2 main projects under good advances for license to commercialise, one an incremental innovation at late stage (Phase 3), with a patent to be filed soon, and another one, that is a vaccine for colitis, at an early stage, already holding a patent, a radical innovation. Both with different risks involved, but with good preliminary data and rationale for each stage, which give us leverage to negotiate. What we are struggling with is to find a Pharma partner to invest in or even a suitable investor that may be interested in a good deal. We have seen lately that the scientific discussions are easy to handle, but negotiating pricing and some costs, are still the challenge here, in order to proceed with an international party.